Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Notes Payables (2016 - 2021)

Historic Notes Payables for STRATA Skin Sciences (SSKN) over the last 7 years, with Q2 2021 value amounting to $7.3 million.

  • STRATA Skin Sciences' Notes Payables changed 0.0% to $7.3 million in Q2 2021 from the same period last year, while for Jun 2021 it was $7.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.3 million for FY2020, which is 0.0% changed from last year.
  • Per STRATA Skin Sciences' latest filing, its Notes Payables stood at $7.3 million for Q2 2021, which was down 0.0% from $7.3 million recorded in Q1 2021.
  • In the past 5 years, STRATA Skin Sciences' Notes Payables registered a high of $7.3 million during Q4 2019, and its lowest value of $34000.0 during Q3 2017.
  • In the last 5 years, STRATA Skin Sciences' Notes Payables had a median value of $7.3 million in 2019 and averaged $4.0 million.
  • In the last 5 years, STRATA Skin Sciences' Notes Payables soared by 4731.18% in 2017 and then crashed by 6277.37% in 2018.
  • Over the past 5 years, STRATA Skin Sciences' Notes Payables (Quarter) stood at $357000.0 in 2017, then plummeted by 85.71% to $51000.0 in 2018, then skyrocketed by 14164.71% to $7.3 million in 2019, then changed by 0.0% to $7.3 million in 2020, then changed by 0.0% to $7.3 million in 2021.
  • Its Notes Payables stands at $7.3 million for Q2 2021, versus $7.3 million for Q1 2021 and $7.3 million for Q4 2020.